APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Selected research

Market Structure

Global Therapeutic Drug Monitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchTherapeutic Drug Monitoring Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Drug Monitoring Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Therapeutic Drug Monitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Drug Monitoring Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Drug Monitoring Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.

Report Includes

Read the full market overview

This report provides an overview of the global Therapeutic Drug Monitoring market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Therapeutic Drug Monitoring and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Drug Monitoring revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Therapeutic Drug Monitoring market size, projected growth trends, production technologies, key applications, and end-use industries.

Therapeutic Drug Monitoring Segment by Company

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Sanquin

Becton Dickinson

Quest Diagnostics

Therapeutic Drug Monitoring Segment by Type

Blood Test

Urine Test

Saliva Test

Other Test

Therapeutic Drug Monitoring Segment by Application

Hospital Labs

Private Labs

Others

Therapeutic Drug Monitoring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Therapeutic Drug Monitoring in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Therapeutic Drug Monitoring industry.

Chapter 3: Detailed analysis of Therapeutic Drug Monitoring companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Drug Monitoringrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Blood Test Table 3. Key Players of Urine Test Table 4. Key Players of Saliva Test Table 3. Key Players of Other Test Table 4. Global Therapeutic Drug Monitoring Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Labs Table 6. Key Players of Private Labs Table 7. Key Players of Others Table 8. Global Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Therapeutic Drug Monitoring Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Therapeutic Drug Monitoring Market Share by Region (2021-2026) Table 11. Global Therapeutic Drug Monitoring Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Therapeutic Drug Monitoring Market Share by Region (2027-2032) Table 13. Therapeutic Drug Monitoring Industry Trends Table 14. Therapeutic Drug Monitoring Industry Drivers Table 15. Therapeutic Drug Monitoring Industry Opportunities and Challenges Table 16. Therapeutic Drug Monitoring Industry Restraints Table 17. Global Therapeutic Drug Monitoring Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Therapeutic Drug Monitoring Revenue Market Share by Company (2021-2026) Table 19. Global Therapeutic Drug Monitoring Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Therapeutic Drug Monitoring Key Company Head Office and Area Served Table 21. Global Therapeutic Drug Monitoring Company, Product Type & Application Table 22. Global Therapeutic Drug Monitoring Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Therapeutic Drug Monitoring Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Therapeutic Drug Monitoring Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2021-2026) Table 29. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2027-2032) Table 30. Global Therapeutic Drug Monitoring Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Therapeutic Drug Monitoring Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021-2026) Table 34. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2027-2032) Table 35. Roche Company Information Table 36. Roche Business Overview Table 37. Roche Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Roche Therapeutic Drug Monitoring Product Portfolio Table 39. Roche Recent Development Table 40. Danaher Company Information Table 41. Danaher Business Overview Table 42. Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Danaher Therapeutic Drug Monitoring Product Portfolio Table 44. Danaher Recent Development Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Abbott Therapeutic Drug Monitoring Product Portfolio Table 49. Abbott Recent Development Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio Table 54. Thermo Fisher Scientific Recent Development Table 55. Siemens Healthcare Company Information Table 56. Siemens Healthcare Business Overview Table 57. Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio Table 59. Siemens Healthcare Recent Development Table 60. Bio-Rad Laboratories Company Information Table 61. Bio-Rad Laboratories Business Overview Table 62. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio Table 64. Bio-Rad Laboratories Recent Development Table 65. BioMerieux Company Information Table 66. BioMerieux Business Overview Table 67. BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. BioMerieux Therapeutic Drug Monitoring Product Portfolio Table 69. BioMerieux Recent Development Table 70. Sanquin Company Information Table 71. Sanquin Business Overview Table 72. Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Sanquin Therapeutic Drug Monitoring Product Portfolio Table 74. Sanquin Recent Development Table 75. Becton Dickinson Company Information Table 76. Becton Dickinson Business Overview Table 77. Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Becton Dickinson Therapeutic Drug Monitoring Product Portfolio Table 79. Becton Dickinson Recent Development Table 80. Quest Diagnostics Company Information Table 81. Quest Diagnostics Business Overview Table 82. Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio Table 84. Quest Diagnostics Recent Development Table 85. North America Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Therapeutic Drug Monitoring Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Therapeutic Drug Monitoring Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Therapeutic Drug Monitoring Market Size by Country (2021-2026) Table 91. North America Therapeutic Drug Monitoring Market Size by Country (2027-2032) Table 92. Europe Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Therapeutic Drug Monitoring Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Therapeutic Drug Monitoring Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Therapeutic Drug Monitoring Market Size by Country (2021-2026) Table 98. Europe Therapeutic Drug Monitoring Market Size by Country (2027-2032) Table 99. China Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 100. China Therapeutic Drug Monitoring Market Size by Type (2027-2032) & (US$ Million) Table 101. China Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 102. China Therapeutic Drug Monitoring Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Therapeutic Drug Monitoring Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Therapeutic Drug Monitoring Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Therapeutic Drug Monitoring Market Size by Country (2021-2026) Table 109. Asia Therapeutic Drug Monitoring Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Therapeutic Drug Monitoring Product Image Figure 2. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Therapeutic Drug Monitoring Market Share by Type: 2025 VS 2032 Figure 4. Blood Test Image Figure 5. Urine Test Image Figure 6. Saliva Test Image Figure 7. Other Test Image Figure 8. Global Therapeutic Drug Monitoring Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Therapeutic Drug Monitoring Market Share by Application: 2025 VS 2032 Figure 10. Hospital Labs Image Figure 11. Private Labs Image Figure 12. Others Image Figure 13. Global Therapeutic Drug Monitoring Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 15. Global Therapeutic Drug Monitoring Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Therapeutic Drug Monitoring Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Therapeutic Drug Monitoring Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Therapeutic Drug Monitoring Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2021-2032) Figure 22. Global Therapeutic Drug Monitoring Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021-2032) Figure 24. North America Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 25. North America Therapeutic Drug Monitoring Market Share by Type (2021-2032) Figure 26. North America Therapeutic Drug Monitoring Market Share by Application (2021-2032) Figure 27. North America Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 28. United States Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 29. Canada Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 31. Europe Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 32. Europe Therapeutic Drug Monitoring Market Share by Type (2021-2032) Figure 33. Europe Therapeutic Drug Monitoring Market Share by Application (2021-2032) Figure 34. Europe Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 35. Germany Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 36. France Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 38. Italy Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 39. Russia Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 41. China Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 42. China Therapeutic Drug Monitoring Market Share by Type (2021-2032) Figure 43. China Therapeutic Drug Monitoring Market Share by Application (2021-2032) Figure 44. Asia Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 45. Asia Therapeutic Drug Monitoring Market Share by Type (2021-2032) Figure 46. Asia Therapeutic Drug Monitoring Market Share by Application (2021-2032) Figure 47. Asia Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 48. Japan Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 52. India Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 53. Australia Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Therapeutic Drug Monitoring Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Therapeutic Drug Monitoring Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2021-2032) Figure 58. Brazil Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 63. UAE Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 65. Chile Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Test
  • Urine Test
  • Saliva Test
  • Other Test
Applications
  • Hospital Labs
  • Private Labs
  • Others
Companies covered
  • Roche
  • Danaher
  • Abbott
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • BioMerieux
  • Sanquin
  • Becton Dickinson
  • Quest Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Test
  5. 1.2.3 Urine Test
  6. 1.2.4 Saliva Test
  7. 1.2.5 Other Test
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Labs
  11. 1.3.3 Private Labs
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Therapeutic Drug Monitoring Growth Trends by Region
  15. 1.5.1 Global Therapeutic Drug Monitoring Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Therapeutic Drug Monitoring Market Size by Region (2021-2026)
  17. 1.5.3 Therapeutic Drug Monitoring Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Therapeutic Drug Monitoring Market Dynamics
  1. 2.1 Therapeutic Drug Monitoring Industry Trends
  2. 2.2 Therapeutic Drug Monitoring Industry Drivers
  3. 2.3 Therapeutic Drug Monitoring Industry Opportunities and Challenges
  4. 2.4 Therapeutic Drug Monitoring Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Therapeutic Drug Monitoring Revenue by Company (2021-2026)
  2. 3.2 Global Therapeutic Drug Monitoring Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Therapeutic Drug Monitoring Key Company Head office and Area Served
  4. 3.4 Global Therapeutic Drug Monitoring Company, Product Type & Application
  5. 3.5 Global Therapeutic Drug Monitoring Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Therapeutic Drug Monitoring Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Therapeutic Drug Monitoring Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Therapeutic Drug Monitoring Tier 1, Tier 2, and Tier 3
4 Therapeutic Drug Monitoring Market by Type
  1. 4.1 Global Therapeutic Drug Monitoring Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Therapeutic Drug Monitoring Market Size by Type (2021-2032)
  3. 4.3 Global Therapeutic Drug Monitoring Market Size Share by Type (2021-2032)
5 Therapeutic Drug Monitoring Market by Application
  1. 5.1 Global Therapeutic Drug Monitoring Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Therapeutic Drug Monitoring Market Size by Application (2021-2032)
  3. 5.3 Global Therapeutic Drug Monitoring Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Therapeutic Drug Monitoring Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Danaher
  8. 6.2.1 Danaher Company Information
  9. 6.2.2 Danaher Business Overview
  10. 6.2.3 Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Danaher Therapeutic Drug Monitoring Product Portfolio
  12. 6.2.5 Danaher Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Abbott Therapeutic Drug Monitoring Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 Siemens Healthcare
  26. 6.5.1 Siemens Healthcare Company Information
  27. 6.5.2 Siemens Healthcare Business Overview
  28. 6.5.3 Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio
  30. 6.5.5 Siemens Healthcare Recent Developments
  31. 6.6 Bio-Rad Laboratories
  32. 6.6.1 Bio-Rad Laboratories Company Information
  33. 6.6.2 Bio-Rad Laboratories Business Overview
  34. 6.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories Recent Developments
  37. 6.7 BioMerieux
  38. 6.7.1 BioMerieux Company Information
  39. 6.7.2 BioMerieux Business Overview
  40. 6.7.3 BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 BioMerieux Therapeutic Drug Monitoring Product Portfolio
  42. 6.7.5 BioMerieux Recent Developments
  43. 6.8 Sanquin
  44. 6.8.1 Sanquin Company Information
  45. 6.8.2 Sanquin Business Overview
  46. 6.8.3 Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sanquin Therapeutic Drug Monitoring Product Portfolio
  48. 6.8.5 Sanquin Recent Developments
  49. 6.9 Becton Dickinson
  50. 6.9.1 Becton Dickinson Company Information
  51. 6.9.2 Becton Dickinson Business Overview
  52. 6.9.3 Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio
  54. 6.9.5 Becton Dickinson Recent Developments
  55. 6.10 Quest Diagnostics
  56. 6.10.1 Quest Diagnostics Company Information
  57. 6.10.2 Quest Diagnostics Business Overview
  58. 6.10.3 Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio
  60. 6.10.5 Quest Diagnostics Recent Developments
7 North America
  1. 7.1 North America Therapeutic Drug Monitoring Market Size (2021-2032)
  2. 7.2 North America Therapeutic Drug Monitoring Market Size by Type
  3. 7.2.1 North America Therapeutic Drug Monitoring Market Size by Type (2021-2026)
  4. 7.2.2 North America Therapeutic Drug Monitoring Market Size by Type (2027-2032)
  5. 7.2.3 North America Therapeutic Drug Monitoring Market Share by Type (2021-2032)
  6. 7.3 North America Therapeutic Drug Monitoring Market Size by Application
  7. 7.3.1 North America Therapeutic Drug Monitoring Market Size by Application (2021-2026)
  8. 7.3.2 North America Therapeutic Drug Monitoring Market Size by Application (2027-2032)
  9. 7.3.3 North America Therapeutic Drug Monitoring Market Share by Application (2021-2032)
  10. 7.4 North America Therapeutic Drug Monitoring Market Size by Country
  11. 7.4.1 North America Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  13. 7.4.3 North America Therapeutic Drug Monitoring Market Size by Country (2027-2032)
  14. 7.4.4 North America Therapeutic Drug Monitoring Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Therapeutic Drug Monitoring Market Size (2021-2032)
  2. 8.2 Europe Therapeutic Drug Monitoring Market Size by Type
  3. 8.2.1 Europe Therapeutic Drug Monitoring Market Size by Type (2021-2026)
  4. 8.2.2 Europe Therapeutic Drug Monitoring Market Size by Type (2027-2032)
  5. 8.2.3 Europe Therapeutic Drug Monitoring Market Share by Type (2021-2032)
  6. 8.3 Europe Therapeutic Drug Monitoring Market Size by Application
  7. 8.3.1 Europe Therapeutic Drug Monitoring Market Size by Application (2021-2026)
  8. 8.3.2 Europe Therapeutic Drug Monitoring Market Size by Application (2027-2032)
  9. 8.3.3 Europe Therapeutic Drug Monitoring Market Share by Application (2021-2032)
  10. 8.4 Europe Therapeutic Drug Monitoring Market Size by Country
  11. 8.4.1 Europe Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  13. 8.4.3 Europe Therapeutic Drug Monitoring Market Size by Country (2027-2032)
  14. 8.4.4 Europe Therapeutic Drug Monitoring Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Therapeutic Drug Monitoring Market Size (2021-2032)
  2. 9.2 China Therapeutic Drug Monitoring Market Size by Type
  3. 9.2.1 China Therapeutic Drug Monitoring Market Size by Type (2021-2026)
  4. 9.2.2 China Therapeutic Drug Monitoring Market Size by Type (2027-2032)
  5. 9.2.3 China Therapeutic Drug Monitoring Market Share by Type (2021-2032)
  6. 9.3 China Therapeutic Drug Monitoring Market Size by Application
  7. 9.3.1 China Therapeutic Drug Monitoring Market Size by Application (2021-2026)
  8. 9.3.2 China Therapeutic Drug Monitoring Market Size by Application (2027-2032)
  9. 9.3.3 China Therapeutic Drug Monitoring Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Therapeutic Drug Monitoring Market Size (2021-2032)
  2. 10.2 Asia Therapeutic Drug Monitoring Market Size by Type
  3. 10.2.1 Asia Therapeutic Drug Monitoring Market Size by Type (2021-2026)
  4. 10.2.2 Asia Therapeutic Drug Monitoring Market Size by Type (2027-2032)
  5. 10.2.3 Asia Therapeutic Drug Monitoring Market Share by Type (2021-2032)
  6. 10.3 Asia Therapeutic Drug Monitoring Market Size by Application
  7. 10.3.1 Asia Therapeutic Drug Monitoring Market Size by Application (2021-2026)
  8. 10.3.2 Asia Therapeutic Drug Monitoring Market Size by Application (2027-2032)
  9. 10.3.3 Asia Therapeutic Drug Monitoring Market Share by Application (2021-2032)
  10. 10.4 Asia Therapeutic Drug Monitoring Market Size by Country
  11. 10.4.1 Asia Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  13. 10.4.3 Asia Therapeutic Drug Monitoring Market Size by Country (2027-2032)
  14. 10.4.4 Asia Therapeutic Drug Monitoring Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Therapeutic Drug Monitoring Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Therapeutic Drug Monitoring Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst